Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia

Blood

Volumn 101, Issue 3, 2003, Pages 1063-1070

  Rezvany, Mohammad Reza ^a,b   Jeddi Tehrani, Mahmood ^a,b   Wigzell, Hans ^a,b   Österborg, Anders ^a,b   Mellstedt, Håkan ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Avesina Research Center   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; B CELL LEUKEMIA; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MEMORY CELL; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0037305710     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-03-0746     Document Type: Article

References (38)

1. Johnson TA, Rassenti LZ, Kipps TJ. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol. 1997;158:235-246.
2. Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102:1515-1525.
3. Rezvany MR, Jeddi-Tehrani M, Rabbani H, et al. Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia. Br J Haematol. 2000a;111:608-617.
4. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature. 1988;334:395-402.
5. Jorgensen J, Esser U, Fazekas de St. Groth B, Reay P, Davis M. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature. 1992;355:224-230.
6. Garcia KC, Degano M, Stanfield RL, et al. An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science. 1996;274:209-219.
7. Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci U S A. 1993;90:4319-4323.
8. Mackensen A, Ferradini L, Carcelain G, et al. Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res. 1993;53:3569-3573.
9. Mackensen A, Veelken H, Lahn M, et al. Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblasts. J Mol Med. 1997;75:290-296.
10. Farace F, Angevin E, Poullion I, et al. T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccines. Int J Cancer. 1997;71:972-977.
11. Sensi M, Farina C, Maccalli C, et al. Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine. J Clin Invest. 1997;99:710-717.
12. Sensi M, Farina C, Maccalli C, Anichini A, Berd D, Parmiani G. Intralesional selection of T cell clonotypes in the immune response to melanoma antigens occurring during vaccination. J Immunother. 1998;21:198-204.
13. Farace F, Orlanducci F, Dietrich PY, et al. T cell repertoire in patients with B chronic lymphocytic leukemia: evidence for multiple in vivo T cell clonal expansions. J Immunol. 1994;153:4281-4290.
14. Rezvany MR, Jeddi-Tehrani M, Osterborg A, Kimby E, Wigzell H, Mellstedt H. Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset. Blood. 1999;94:1063-1069.
15. Idestrom K, Kimby E, Bjorkholm M, et al. Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone. Eur J Cancer Clin Oncol. 1982;18:1117-1123.
16. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pastermack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46:219-234.
17. Boyum A. Separation of lymphocytes, lymphocyte subgroups and monocytes: a review. Lymphology. 1977;10:71-76.
18. Avila-Carino J, Lewin N, Yamamoto K, et al. EBV infection of B-CLL cells in vitro potentiates their allostimulatory capacity if accompanied by acquisition of the activated phenotype. Int J Cancer. 1994;58:678-685.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
20. Doherty JP, Roifman MC, Sueihua P, et al. Expression of the human T cell receptor Vβ repertoire. Mol Immunol. 1991;28:607-612.
21. Sambrock J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
22. Grunewald J, Jeddi-Tehrani M, Dersimonian H, Andersson R, Wigzell H. A persistent T-cell expansion in the peripheral blood of a normal adult male: a new clinical entity? Clin Exp Immunol. 1992;89:279-284.
23. + T cell subsets in chronic lymphocytic leukemia. J Immunol. 1997;158:1482-1489.
24. Rezvany MR, Jeddi-Tehrani M, Rabbani H, et al. Autologous T lymphocytes recognize the tumour-derived immunoglobulin VH-CDR3 region in patients with B-cell chronic lymphocytic leukaemia. Br J Haematol. 2000b;111:230-238.
25. Rock EP, Sibbald PR, Davis MM, Chien YH. CDR3 length in antigen-specific immune receptors. J Exp Med. 1994;179:323-328.
26. Halapi E. Oligoclonal T cells in human cancer. Med Oncol. 1998;15:203-211.
27. + T cells in health and disease: aging, infection, or immune regulation? Hum Immunol. 1996;48:68-76.
28. Sensi M, Parmiani G. Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol Today. 1995;16:588-595.
29. Alatrakchi N, Farace F, Frau E, Carde P, Munck JN, Triebel F. T-cell clonal expansion in patients with B-cell lymphoproliferative disorders. J Immunother. 1998;21:363-370.
30. Brown RD, Yuen E, Nelson M, Gibson J, Joshua D. The prognostic significance of T cell receptor beta gene rearrangements and idiotype-reactive T cells in multiple myeloma. Leukemia. 1997;11:1312-1317.
31. Newton DW, Dohlsten M, Lando PA, Kalland T, Olsson C, Kotb M. MHC class II-independent, Vβ-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma. Int J Mol Med. 1998;1:157-162.
32. Echchakir H, Asselin-Paturel C, Dorothee G, et al. Analysis of T-cell receptor β-chain gene usage in peripheral-blood and tumor-infiltrating lymphocytes from human non-small-cell lung carcinomas. IntJ Cancer. 1999;81:205-213.
33. van de Corput L, Kluin-Nelemans HC, Kester MG, Willemze R, Falkenburg JH. Hairy cell leukemia-specific recognition by multiple autologous HLA-DQ or DP-restricted T-cell clones. Blood. 1999;93:251-259.
34. Jager E, Maeurer M, Hohn H, et al. Clonal expansion of melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides. Int J Cancer. 2000;86:538-547.
35. + T cell clones in elderly humans. J Immunol. 1997;158:4493-4499.
36. Campos-Lima PO, Levitsky V, Imreh MP, Gavioli R, Masucci MG. Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus. J Exp Med. 1997;186:83-89.
37. Rassenti LZ, Avery E, Cantwell M, Kipps TJ. T-cell response to infusion of Ad-CD154 transfused leukemia B cells in the patients with chronic lymphocytic leukemia [abstractl. Proceedings of the 4th Annual Meeting of the American Society of Hematology, Miami Beach, FL. Philadelphia, PA: WB Saunders; 1998:666.
38. Wierda WG, Cantwell MJ, Woods SJ, Rassenti LZ, Prussak CE, Kipps TJ. CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia. Blood. 2000;96:2917-2924.